Search

everythinglearnresearchcommunity

for

Search:↓

The method accurately measures certain steroids in human hair, showing different levels in males and females.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Androgens reduce hair growth by affecting cell differentiation and blood vessel formation.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Androgens may influence bladder cancer progression by affecting cellular behavior.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Australian dermatologists often prescribe spironolactone and minoxidil for female hair loss.

Increased androgen receptor expression in certain hair follicle areas may cause male pattern baldness.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

High adrenal sex hormones in dogs with hypercortisolemia can mislead adrenal hyperplasia diagnosis.

Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.

Hair loss in postmenopausal woman caused by ovarian issue.

Androgen-driven traits don't predict prostate cancer recurrence.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Cyclosporin and minoxidil promote hair growth.

Testosterone affects stress hormone levels differently in adolescent and adult male rats.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Androgen receptor differences may contribute to hair loss in AGA patients.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.